Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.1%1-day move

₹1840.00

prior close

₹1838.50

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.0+0.0+0.1+0.1+0.1+0.0-2.0-2.7-2.9-3.2-1.9+1.2+7.2—

Up moveDown movePending

AI summary

Sun Pharmaceutical Industries has disclosed the schedule of an upcoming analyst and institutional investor meeting. The company will participate in the 360 ONE Capital (B&K) 16th Annual Investor Conference called TRINITY INDIA 2026 on 27 May 2026 in Mumbai. The meeting will be held physically and includes both group and one-on-one sessions. The company has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during these meetings. This is a routine regulatory disclosure required under SEBI listing regulations.

Likely market impact

This is a standard compliance filing with no material information. The meeting schedule informs the market about planned investor engagement but does not contain any price-sensitive details that would directly impact the stock.